Josephine W Kimani (Josephine Kimani)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 11

Top Topics

Immune Response

High Fat Diet Induced

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Divine Ainee Celise, James Kimotho, Josephine W Kimani, Alex Kigundu Muriithi, Eddy Okoth Odari
Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide. Vaccines 11 (1) (2022)
Ernest Z Manson, Mutinda C Kyama, Josephine W Kimani, Aleksandra Bocian, Konrad Kamil Hus, Vladimír Petrilla, Jaroslav Legáth, James H Kimotho
Development and Characterization of Anti- Naja ashei Three-Finger Toxins (3FTxs)-Specific Monoclonal Antibodies and Evaluation of Their In Vitro Inhibition Activity. Toxins 14 (4) (2022)
Divine Ainee Celise, James Kimotho, Josephine W Kimani, Alex Kigundu Muriithi, Eddy Okoth Odari
Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide. Vaccines 11 (1) (2022)
Angela Muraya, Cecilia Kyany'a, Shahiid Kiyaga, Maj Hunter Jackson Smith, Caleb Kipkurui Kibet, Melissa J Martin, Josephine W Kimani, Lillian Musila
Antimicrobial Resistance and Virulence Characteristics of Klebsiella pneumoniae Isolates in Kenya by Whole-Genome Sequencing. Pathogens (Basel, Switzerland) 11 (5) (2022)
Muunda Mudenda, Josephine W Kimani, Johnson Kinyua, James Kimotho
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice. Vaccines 11 (1) (2022)
Divine Ainee Celise, James Kimotho, Josephine W Kimani, Alex Kigundu Muriithi, Eddy Okoth Odari
Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide. Vaccines 11 (1) (2022)
Muunda Mudenda, Josephine W Kimani, Johnson Kinyua, James Kimotho
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice. Vaccines 11 (1) (2022)
Muunda Mudenda, Josephine W Kimani, Johnson Kinyua, James Kimotho
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice. Vaccines 11 (1) (2022)
Muunda Mudenda, Josephine W Kimani, Johnson Kinyua, James Kimotho
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice. Vaccines 11 (1) (2022)
Muunda Mudenda, Josephine W Kimani, Johnson Kinyua, James Kimotho
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice. Vaccines 11 (1) (2022)
Divine Ainee Celise, James Kimotho, Josephine W Kimani, Alex Kigundu Muriithi, Eddy Okoth Odari
Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide. Vaccines 11 (1) (2022)